LOS ANGELES CAPITAL MANAGEMENT LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$357,000
-0.3%
123,970
+5.3%
0.00%0.0%
Q4 2021$358,000
-64.3%
117,681
-17.7%
0.00%
-80.0%
Q3 2021$1,002,000
+312.3%
142,941
+439.6%
0.01%
+400.0%
Q2 2021$243,000
+64.2%
26,489
+73.6%
0.00%0.0%
Q1 2021$148,000
-81.8%
15,259
-80.4%
0.00%
-75.0%
Q2 2020$812,000
+46.0%
77,816
+18.2%
0.00%0.0%
Q1 2020$556,000
+23.3%
65,861
+27.7%
0.00%
+100.0%
Q4 2019$451,000
+62.2%
51,591
+99.9%
0.00%0.0%
Q3 2019$278,000
-17.8%
25,806
+196.1%
0.00%0.0%
Q1 2019$338,000
-44.8%
8,714
-34.7%
0.00%
-33.3%
Q3 2018$612,000
-79.5%
13,339
-73.5%
0.00%
-81.2%
Q2 2018$2,981,000
+80.4%
50,399
+107.6%
0.02%
+77.8%
Q1 2018$1,652,000
+439.9%
24,279
+850.6%
0.01%
+350.0%
Q3 2017$306,000
-61.7%
2,554
-90.5%
0.00%
-71.4%
Q2 2016$798,000
+179.0%
26,794
+994.1%
0.01%
+133.3%
Q2 2015$286,000
-67.7%
2,449
-34.8%
0.00%
-62.5%
Q1 2015$886,0003,7540.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$4,713,2604.15%
Eversept Partners, LP 1,681,149$4,421,4220.37%
Camber Capital Management LP 4,235,000$11,1380.37%
Kynam Capital Management, LP 473,975$1,246,5540.20%
GLOBEFLEX CAPITAL L P 538,559$1,416,4100.17%
Affinity Asset Advisors, LLC 202,349$532,1780.15%
GSA CAPITAL PARTNERS LLP 279,629$7350.06%
RICE HALL JAMES & ASSOCIATES, LLC 363,666$956,4420.06%
Patriot Financial Group Insurance Agency, LLC 67,000$176,2100.04%
ACADIAN ASSET MANAGEMENT LLC 1,858,000$4,8840.02%
View complete list of PUMA BIOTECHNOLOGY INC shareholders